163 related articles for article (PubMed ID: 25404440)
41. [Application of ischemic preconditioning before hepatic vascular exclusion for resection of hepatocellular carcinoma].
Ji XQ; Li CL; Yang JC; Liu XG; Wang ML; Liu ZQ; Lin JH
Di Yi Jun Yi Da Xue Xue Bao; 2004 Jan; 24(1):66-8, 71. PubMed ID: 14724101
[TBL] [Abstract][Full Text] [Related]
42. Longterm prognosis after hepatic resection for small hepatocellular carcinoma.
Shimozawa N; Hanazaki K
J Am Coll Surg; 2004 Mar; 198(3):356-65. PubMed ID: 14992736
[TBL] [Abstract][Full Text] [Related]
43. Model for End-stage Liver Disease score fails to predict perioperative outcome after hepatic resection for hepatocellular carcinoma in patients without cirrhosis.
Teh SH; Sheppard BC; Schwartz J; Orloff SL
Am J Surg; 2008 May; 195(5):697-701. PubMed ID: 18367132
[TBL] [Abstract][Full Text] [Related]
44. Beneficial effects of S-adenosyl-L-methionine on post-hepatectomy residual liver function: a prospective, randomized, controlled clinical trial.
Su ZR; Cui ZL; Ma JL; Li JS; Ge YS; Yu JH; Pan JH; Xu GL; Jia WD
Hepatogastroenterology; 2013; 60(125):1136-41. PubMed ID: 23491928
[TBL] [Abstract][Full Text] [Related]
45. Effects of human hepatocyte growth factor on the proliferation of human hepatocytes and hepatocellular carcinoma cell lines.
Efimova EA; Glanemann M; Liu L; Schumacher G; Settmacher U; Jonas S; Langrehr JM; Neuhaus P; Nüssler AK
Eur Surg Res; 2004; 36(5):300-7. PubMed ID: 15359093
[TBL] [Abstract][Full Text] [Related]
46. Kukoamine B promotes TLR4-independent lipopolysaccharide uptake in murine hepatocytes.
Yang D; Zheng X; Wang N; Fan S; Yang Y; Lu Y; Chen Q; Liu X; Zheng J
Oncotarget; 2016 Sep; 7(36):57498-57513. PubMed ID: 27542278
[TBL] [Abstract][Full Text] [Related]
47. [Impact of surgical operation-related factors on long-term survival of patients with hepatocellular carcinoma after hepatectomy].
Lü WP; Dong JH; Zhang WZ; Huang XQ; Wang SG; Bie P
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Aug; 30(4):386-92. PubMed ID: 18795607
[TBL] [Abstract][Full Text] [Related]
48. Prediction of postoperative complications in elderly patients with hepatocellular carcinoma.
Ide T; Miyoshi A; Kitahara K; Noshiro H
J Surg Res; 2013 Dec; 185(2):614-9. PubMed ID: 23932657
[TBL] [Abstract][Full Text] [Related]
49. Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy.
Mullen JT; Ribero D; Reddy SK; Donadon M; Zorzi D; Gautam S; Abdalla EK; Curley SA; Capussotti L; Clary BM; Vauthey JN
J Am Coll Surg; 2007 May; 204(5):854-62; discussion 862-4. PubMed ID: 17481498
[TBL] [Abstract][Full Text] [Related]
50. Cigarette smoking increases risk of early morbidity after hepatic resection in patients with hepatocellular carcinoma.
Lv Y; Liu C; Wei T; Zhang JF; Liu XM; Zhang XF
Eur J Surg Oncol; 2015 Apr; 41(4):513-9. PubMed ID: 25656703
[TBL] [Abstract][Full Text] [Related]
51. Hepatectomy for hepatocellular carcinoma: patient selection and postoperative outcome.
Poon RT; Fan ST
Liver Transpl; 2004 Feb; 10(2 Suppl 1):S39-45. PubMed ID: 14762838
[TBL] [Abstract][Full Text] [Related]
52. Using indocyanine green test to avoid post-hepatectomy liver dysfunction.
Lee CF; Yu MC; Kuo LM; Chan KM; Jan YY; Chen MF; Lee WC
Chang Gung Med J; 2007; 30(4):333-8. PubMed ID: 17939263
[TBL] [Abstract][Full Text] [Related]
53. Use of
Wang MH; Chien CY; Yu HM; Wang PY; Lin WJ
Mol Pharm; 2018 Oct; 15(10):4417-4425. PubMed ID: 30102864
[TBL] [Abstract][Full Text] [Related]
54. Prediction of postoperative outcome after hepatectomy with a new bedside test for maximal liver function capacity.
Stockmann M; Lock JF; Riecke B; Heyne K; Martus P; Fricke M; Lehmann S; Niehues SM; Schwabe M; Lemke AJ; Neuhaus P
Ann Surg; 2009 Jul; 250(1):119-25. PubMed ID: 19561474
[TBL] [Abstract][Full Text] [Related]
55. Radiolabeled constructs for evaluation of the asialoglycoprotein receptor status and hepatic functional reserves.
Abe M; Lai J; Kortylewicz ZP; Nagata H; Fox IJ; Enke CA; Baranowska-Kortylewicz J
Bioconjug Chem; 2003; 14(5):997-1006. PubMed ID: 13129404
[TBL] [Abstract][Full Text] [Related]
56. [Influential factors for failure of enhanced recovery after surgery from hepatectomy for hepatocellular carcinoma and the establishment of risk prediction model].
Wang RD; Jia WD; Ge YS; Ma JL; Xu GL
Zhonghua Wai Ke Za Zhi; 2018 Sep; 56(9):693-700. PubMed ID: 30157576
[No Abstract] [Full Text] [Related]
57. Evaluation of liver function for the application of preoperative portal vein embolization on major hepatic resection.
Wakabayashi H; Yachida S; Maeba T; Maeta H
Hepatogastroenterology; 2002; 49(46):1048-52. PubMed ID: 12143199
[TBL] [Abstract][Full Text] [Related]
58. Hepatic function immediately after hepatectomy as a significant risk factor for early recurrence in hepatocellular carcinoma.
Hanazaki K; Wakabayashi M; Sodeyama H; Kajikawa S; Amano J
Hepatogastroenterology; 1999; 46(30):3201-7. PubMed ID: 10626186
[TBL] [Abstract][Full Text] [Related]
59. ASGPR-Mediated Uptake of Multivalent Glycoconjugates for Drug Delivery in Hepatocytes.
Monestier M; Charbonnier P; Gateau C; Cuillel M; Robert F; Lebrun C; Mintz E; Renaudet O; Delangle P
Chembiochem; 2016 Apr; 17(7):590-4. PubMed ID: 26781030
[TBL] [Abstract][Full Text] [Related]
60. Acoustic radiation force impulse imaging predicts postoperative ascites resulting from curative hepatic resection for hepatocellular carcinoma.
Harada N; Shirabe K; Ijichi H; Matono R; Uchiyama H; Yoshizumi T; Taketomi A; Soejima Y; Maehara Y
Surgery; 2012 Jun; 151(6):837-43. PubMed ID: 22386275
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
